Liu Xiaodong,Li Shoulin,Jiang Junhai,et al.Analysis of causes of chronic kidney disease associated with conservative treatment of neurogenic bladder in children[J].Journal of Clinical Pediatric Surgery,2021,20(11):1011-1015.[doi:10.12260/lcxewkzz.2021.11.003]
小儿神经源性膀胱保守治疗期间伴发慢性肾病的相关因素分析
- Title:
- Analysis of causes of chronic kidney disease associated with conservative treatment of neurogenic bladder in children
- 分类号:
- R726.945;R726.9;R726.92
- 摘要:
- 目的 回顾性分析小儿神经源性膀胱患者的诊治过程，探讨其在保守治疗期间伴发慢性肾病的相关因素。方法 研究对象为2015年1月至2020年1月期间深圳市儿童医院收治的25例神经源性膀胱患者，将所有患者分为两组：伴发慢性肾病G3期及以上者为A组，伴发慢性肾病G3期以下者为B组；根据血肌酐水平，通过公式测算得到所有患者肾小球滤过率（estimated glomerular filtration rate，eGFR）。收集两组年龄、性别等一般资料以及eGFR、开始间歇导尿时间、随访情况等临床资料，并进行统计学分析。结果 两组年龄、性别差异无统计学意义（P>0.05）。A、B组eGFR分别为（23.6±13.8） mL·min-1·1.73 m-2和（89.3±17.3） mL·min-1·1.73 m-2，差异有统计学意义（P<0.05）；A、B组开始清洁间歇导尿的年龄分别为4（3，5）岁和2（2，3.25）岁。A、B组确诊神经源性膀胱后第1年在泌尿外科门诊随访次数分别为2（1，2）次和4（3，4.25）次。发热性尿路感染发生次数A、B组分别为3（3，4）次、2（1，1.25）次，差异有统计学意义（P<0.05）。结论 小儿神经源性膀胱保守治疗期间可伴发慢性肾病，未能实施早期清洁间歇导尿、规范随访和控制发热性尿路感染是导致保守治疗期间伴发慢性肾病的相关因素。
- Abstract:
- Objective To explore the causes of chronic kidney disease (CKD) due to neurogenic bladder (NB) in children during the conservative treatment. Methods A retrospective study was conducted for 25 children with neurogenic bladder from January 2015 to January 2020. The patients’ estimated glomerular filtration rate (eGFR) was measured by Schwartz formula based upon serum creatinine level. They were divided into two groups. Group A:patients with CKD stage 3 or above (n=8). Group B:patients with CKD stage 3 below (n=17). Clinical data of two groups were compared and statistically analyzed. Results There was no inter-group statistical difference in age or gender. eGFR was (23.6±13.8) mL·min-1·1.73 m-2 vs. (89.3±17.3) mL·min-1·1.73 m-2 with statistical difference. The age of first cleaning intermittent catheterization was 4(3, 5) vs. 2(2, 3.25) years old, frequency of outpatient follow-up visits in the first year after diagnosis of NB was 2(1, 2) vs. 4(3, 4.25) and the frequency of febrile urinary tract infection (fUTI) was 3(3, 4) vs. 2(1, 2.25), indicating statistically significant differences between two groups. Conclusion CKD may occur during conservative treatment of NB in children. Lack of early clean intermittent catheterization, standardized follow-up and control of fUTI are important contributors for CKD.
参考文献/References:
1 Bauer SB.Neurogenic bladder:etiology and assessment[J].Pediatr Nephrol, 2008, 23(4):541-551.DOI:10.1007/s00467-008-0764-7.
2 de Jong TP, Chrzan R, Klijn AJ, et al. Treatment of the neurogenic bladder in spina bifida[J].Pediatr Nephrol, 2008, 23(6):889-896.DOI:10.1007/s00467-008-0780-7.
3 Nevéus T, von Gontard A, Hoebeke P, et al. The Standardization of Terminology of Lower Urinary Tract Function in Children and Adolescents:Report from the Standardisation Committee of the International Children’s Continence Society[J].Journal of Urology, 2006, 176(1):314-324.DOI:10.1016/s0022-5347(06)00305-3.
4 Manack A, Motsko SP, Haag-Molkenteller C, et al. Epidemiology and healthcare utilization of neurogenic bladder patients in a US claims database[J].Neurourol Urodyn, 2011, 30(3):395-401.DOI:10.1002/nau.21003.
5 Kari JA.Neuropathic bladder as a cause of chronic renal failure in children in developing countries[J].Pediatr Nephrol, 2006, 21(4):517-520.DOI:10.1007/s00467-006-0034-5.
6 Levey AS, Eckardt KU, Tsukamoto Y, et al. Definition and classification of chronic kidney disease:a position statement from Kidney Disease:Improving Global Outcomes (KDIGO)[J].Kidney Int, 2005, 67(6):2089-2100.DOI:10.1111/j.1523-1755.2005.00365.x.
7 Chapter 1:Definition and classification of CKD[J].Kidney Int Suppl (2011), 2013, 3(1):19-62.DOI:10.1038/kisup.2012.64.
8 Schwartz GJ, Munoz A, Schneider MF, et al. New equations to estimate GFR in children with CKD[J].J Am Soc Nephrol, 2009, 20(3):629-637.DOI:10.1681/ASN.2008030287.
9 文建国.小儿正常排尿与神经源性膀胱排尿异常[J].临床小儿外科杂志, 2008, 7(5):63-65.DOI:10.3969/j.issn.1671-6353.2008.05.022. Wen JG.Normal urination and neurogenic bladder urination abnormalities in children[J].J Clin Ped Sur, 2008, 7(5):63-65.DOI:10.3969/j.issn.1671-6353.2008.05.022.
10 Müller T, Arbeiter K, Aufricht C.Renal function in meningomyelocele:risk factors, chronic renal failure, renal replacement therapy and transplantation[J].Curr Opin Urol, 2002, 12(6):479-484.DOI:10.1097/00042307-200211000-00006.
11 Veenboer PW, Bosch JL, van Asbeck FW, et al. Upper and lower urinary tract outcomes in adult myelomeningocele patients:a systematic review[J].PLoS One, 2012, 7(10):e48399.DOI:10.1371/journal.pone.0048399.
12 McGuire EJ, Woodside JR, Borden TA.Upper urinary tract deterioration in patients with myelodysplasia and detrusor hypertonia:a followup study[J].Journal of Urology, 1983, 129(4):823-826.DOI:10.1016/s0022-5347(17)52384-8.
13 Sillén U, Hansson E, Hermansson G, et al. Development of the urodynamic pattern in infants with myelomeningocele[J].Br J Urol, 1996, 78(4):596-601.DOI:10.1046/j.1464-410x.1996.14417.x.
14 郑百俊, 李恭才, 张宪生, 等. 腰骶部脊髓脊膜膨出并发神经源性膀胱的临床研究[J].中华小儿外科杂志, 1997, 18(1):17-19.DOI:10.3760/cma.j.issn.0253-3006.1997.01.008. Zheng BJ, Li GC, Zhang XS, el al.Neurogenic bladder in lumbosacral myelomeningocele[J].Chin J Pediatr Surg, 1997, 18(1):17-19.DOI:10.3760/cma.j.issn.0253-3006.1997.01.008.
15 Wide P, Glad Mattsson G, Mattsson S.Renal preservation in children with neurogenic bladder-sphincter dysfunction followed in a national program[J].J Pediatr Urol, 2012, 8(2):187-193.DOI:10.1016/j.jpurol.2011.02.003.
16 Kaefer M, Pabby A, Kelly M, et al. Improved bladder function after prophylactic treatment of the high risk neurogenic bladder in newborns with myelomentingocele[J].J Urol, 1999, 162(3 Pt 2):1068-1071.DOI:10.1097/00005392-199909000-00031.
17 Dik P, Klijn AJ, van Gool JD, et al. Early start to therapy preserves kidney function in spina bifida patients[J].Eur Urol, 2006, 49(5):908-913.DOI:10.1016/j.eururo.2005.12.056.
18 Wu HY, Baskin LS, Kogan BA.Neurogenic bladder dysfunction due to myelomeningocele:neonatal versus childhood treatment[J].J Urol, 1997, 157(6):2295-2297.
19 Goessl C, Knispel HH, Fiedler U, et al. Urodynamic effects of oral oxybutynin chloride in children with myelomeningocele and detrusor hyperreflexia[J].Urology, 1998, 51(1):94-98.DOI:10.1016/s0090-4295(97)00489-5.
20 Lee JH, Kim KR, Lee YS, et al. Efficacy, tolerability, and safety of oxybutynin chloride in pediatric neurogenic bladder with spinal dysraphism:a retrospective, multicenter, observational study[J].Korean J Urol, 2014, 55(12):828-833.DOI:10.4111/kju.2014.55.12.828.
21 Bauer SB, Austin PF, Rawashdeh YF, et al. International Children’s Continence Society’s recommendations for initial diagnostic evaluation and follow-up in congenital neuropathic bladder and bowel dysfunction in children[J].Neurourol Urodyn, 2012, 31(5):610-614.DOI:10.1002/nau.22247.
22 孙小兵, 李殿国, 罗添华, 等. 膀胱自体扩大术在神经性膀胱患者中的应用评价[J].临床小儿外科杂志, 2016, 15(4):371-373, 378.DOI:10.3969/j.issn.1671-6353.2016.04.018. Sun XB, Li DG, Luo TH, et al. Clinical evaluations of bladder autoaugmentation in children with neurogenic bladder dysfunction[J].J Clin Ped Sur, 2016, 15(4):371-373, 378.DOI:10.3969/j.issn.1671-6353.2016.04.018.
23 Pan Y, Yang Xh, He JP, et al. To be or not to be a doctor, that is the question:a review of serious incidents of violence against doctors in China from 2003-2013[J].Journal of Public Health, 2015, 23(2):111-116.DOI:10.1007/s10389-015-0658-7.
24 Sun J, Liu S, Liu Q, et al. Impact of adverse media reporting on public perceptions of the doctor-patient relationship in China:an analysis with propensity score matching method[J].BMJ Open, 2018, 8(8):e022455.DOI:10.1136/bmjopen-2018-022455.
25 Stein R, Bogaert G, Dogan HS, et al. EAU/ESPU guidelines on the management of neurogenic bladder in children and adolescent part I diagnostics and conservative treatment[J].Neurourol Urodyn, 2020, 39(1):45-57.DOI:10.1002/nau.24211.
26 文建国, 李云龙, 袁继炎, 等. 小儿神经源性膀胱诊断和治疗指南[J].中华小儿外科杂志, 2015, 36(3):163-169.DOI:10.3760/cma.j.issn.0253-3006.2015.03.002. Wen JG, Li YL, Yuan JY, et al. Guidelines for the diagnosis and treatment of neurogenic bladder in children[J].Chin J Pediatr Surg, 2015, 36(3):163-169.DOI:10.3760/cma.j.issn.0253-3006.2015.03.002.
27 Lucas EJ, Baxter C, Singh C, et al. Comparison of the microbiological milieu of patients randomized to either hydrophilic or conventional PVC catheters for clean intermittent catheterization[J].J Pediatr Urol, 2016, 12(3):172.e1-172.e1728.DOI:10.1016/j.jpurol.2015.12.012.
28 Sung BM, Oh DJ, Choi MH, et al. Chronic kidney disease in neurogenic bladder[J].Nephrology, 2018, 23(3):231-236.DOI:10.1111/nep.12990.
相似文献/References:
[1]杨兴欢,陈燕,蒲青崧,等.儿童神经源性膀胱患者上尿路受损的危险因素及其预测价值研究[J].临床小儿外科杂志,2021,20(11):1005.[doi:10.12260/lcxewkzz.2021.11.002]
Yang Xinghuan,Chen Yan,Pu Qingsong,et al.Risk factors and predictors of upper urinary tract damage in pediatric neurogenic bladder[J].Journal of Clinical Pediatric Surgery,2021,20(11):1005.[doi:10.12260/lcxewkzz.2021.11.002]
[2]张志远,钟量,邹翔宇,等.骶神经调控对学龄前期神经源性膀胱患者尿动力学参数的影响[J].临床小儿外科杂志,2021,20(11):1016.[doi:10.12260/lcxewkzz.2021.11.004]
Zhang Zhiyuan,Zhong Liang,Zou Xiangyu,et al.Effect of sacral neuromodulation on urodynamic parameters in preschool children with neurogenic bladder[J].Journal of Clinical Pediatric Surgery,2021,20(11):1016.[doi:10.12260/lcxewkzz.2021.11.004]
[3]周广伦,孙俊杰,尹鉴淳,等.儿童神经源性膀胱并尿路感染的临床特点及病原菌分析[J].临床小儿外科杂志,2021,20(11):1021.[doi:10.12260/lcxewkzz.2021.11.005]
Zhou Guanglun,Sun Junjie,Yin Jianchun,et al.Analysis of pathogens and clinical features of neuropathic bladder with urinary tract infection in children[J].Journal of Clinical Pediatric Surgery,2021,20(11):1021.[doi:10.12260/lcxewkzz.2021.11.005]
[4]王冰蕊,张谦,李骥,等.膀胱扩容术联合输尿管再植术治疗神经源性膀胱的效果分析[J].临床小儿外科杂志,2022,21(10):968.[doi:10.3760/cma.j.cn101785-202201019-012]
Wang Bingrui,Zhang Qian,Li Ji,et al.Analysis of augmentation cystoplasty plus ureter reimplantation for children with neurogenic bladder[J].Journal of Clinical Pediatric Surgery,2022,21(11):968.[doi:10.3760/cma.j.cn101785-202201019-012]
[5]孙小刚,王若义.儿童神经源性膀胱手术治疗进展[J].临床小儿外科杂志,2023,22(10):992.[doi:10.3760/cma.j.cn101785-202108051-017]
Sun Xiaogang,Wang Ruoyi.Recent advances of surgery for children with neurogenic bladder[J].Journal of Clinical Pediatric Surgery,2023,22(11):992.[doi:10.3760/cma.j.cn101785-202108051-017]
备注/Memo
收稿日期:2021-02-24。
基金项目:国家自然科学基金委联合基金项目（编号：U1904208）；广东省医学科学技术研究基金项目（编号：A2018341）；深圳市医疗卫生三名工程（编号：SZSM201612013）；深圳市医学重点学科（编号：（2020-2024）（SZXK035））
通讯作者:李守林,Email:lishoulinsz@126.com